ulcerative colitis bpc 157 🚨 Big News for BPC-157 FDA's own advisory committee voted

FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Ulcerative Colitis treatment: Kim Crawford, M.D. FDA Discusses Peptide Bulk Substances BPC 157 and More Hillary Lin, MD posted on the topic LinkedIn FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr. MedPage Today

SKU: 43012137584 · From vanierexcavation.com